Ng George K 4

What Happened
CEO George K. Ng reported a purchase of 2,129 shares of Processa Pharmaceuticals (PCSA) on 2026-05-29 at $2.57 per share, for a total cost of roughly $5,472. The Form 4 lists the transaction as a purchase (code P — open market or private purchase).

Key Details

• Transaction date and price: 2026-05-29, 2,129 shares @ $2.57 each. Total ≈ $5,472.
• Transaction type: Purchase (code P — open market or private purchase as reported).
• Shares owned after transaction: Not disclosed in the provided filing.
• Filing date: Form 4 filed 2026-06-01; filing appears timely (within required business-day window).
• Footnotes/flags: No special footnotes (e.g., 10b5-1, tax withholding) provided in the supplied data.

Context
Insider purchases can be viewed positively by investors because they increase executive ownership, but this particular buy is modest in dollar value and may be immaterial alone. This report confirms the CEO purchased shares; it does not explain motivation or signal a material change in position. Retail investors should consider this alongside other insider activity, company fundamentals, and news.